Literature DB >> 11273440

Principles of good clinical practice (GCP) in clinical research.

D Switula1.   

Abstract

Good Clinical Practice is an international quality standard for conducting trials that involve participation of human subjects. Currently, the most widely accepted international document forming the base for GCP is the ICH Harmonised Tripartite Guideline for GCP, which defines in detail the responsibilities and obligations of parties engaged in clinical research. The purpose of this paper is to analyse how compliance with GCP provides protection of the trial subjects and assures quality and credibility of the data obtained.

Entities:  

Keywords:  Biomedical and Behavioral Research; International Conference on Harmonization

Mesh:

Year:  2000        PMID: 11273440     DOI: 10.1007/s11948-000-0025-z

Source DB:  PubMed          Journal:  Sci Eng Ethics        ISSN: 1353-3452            Impact factor:   3.525


  16 in total

1.  Snail immunohistochemical overexpression correlates to recurrence risk in non-muscle invasive bladder cancer: results from a longitudinal cohort study.

Authors:  Raffaella Santi; Tommaso Cai; Stefania Nobili; Ilaria Camilla Galli; Andrea Amorosi; Eva Comperat; Gabriella Nesi
Journal:  Virchows Arch       Date:  2018-03-10       Impact factor: 4.064

2.  Loss of heterozygosis on chromosome 18q21-23 and muscle-invasive bladder cancer natural history.

Authors:  Tommaso Cai; Nicola Mondaini; Daniele Tiscione; Maurizio Dal Canto; Raffaella Santi; Riccardo Bartoletti; Gabriella Nesi
Journal:  Oncol Lett       Date:  2015-08-17       Impact factor: 2.967

3.  Third-wave cognitive therapy versus mentalisation-based treatment for major depressive disorder: a randomised clinical trial.

Authors:  Janus Christian Jakobsen; Christian Gluud; Mickey Kongerslev; Kirsten Aaskov Larsen; Per Sørensen; Per Winkel; Theis Lange; Ulf Søgaard; Erik Simonsen
Journal:  BMJ Open       Date:  2014-08-19       Impact factor: 2.692

4.  Moon phases and moon signs do not influence morbidity, mortality and long-term survival, after living donor kidney transplantation.

Authors:  A Kleespies; M Mikhailov; P N Khalil; S Pratschke; A Khandoga; M Stangl; W D Illner; M K Angele; K W Jauch; M Guba; J Werner; M Rentsch
Journal:  BMC Complement Altern Med       Date:  2017-09-04       Impact factor: 3.659

5.  Study of the integrated immune response induced by an inactivated EV71 vaccine.

Authors:  Longding Liu; Ying Zhang; Jingjing Wang; Hongling Zhao; Li Jiang; Yanchun Che; Haijin Shi; Rongcheng Li; Zhaojun Mo; Teng Huang; Zhenglun Liang; Qunying Mao; Lichun Wang; Chenghong Dong; Yun Liao; Lei Guo; Erxia Yang; Jing Pu; Lei Yue; Zhenxin Zhou; Qihan Li
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

6.  'Third wave' cognitive therapy versus mentalization-based therapy for major depressive disorder. A protocol for a randomised clinical trial.

Authors:  Janus Christian Jakobsen; Christian Gluud; Mickey Kongerslev; Kirsten Aaskov Larsen; Per Sørensen; Per Winkel; Theis Lange; Ulf Søgaard; Erik Simonsen
Journal:  BMC Psychiatry       Date:  2012-12-19       Impact factor: 3.630

7.  Prevention of low back pain: effect, cost-effectiveness, and cost-utility of maintenance care - study protocol for a randomized clinical trial.

Authors:  Andreas Eklund; Iben Axén; Alice Kongsted; Malin Lohela-Karlsson; Charlotte Leboeuf-Yde; Irene Jensen
Journal:  Trials       Date:  2014-04-02       Impact factor: 2.279

8.  The practice of 'doing' evaluation: lessons learned from nine complex intervention trials in action.

Authors:  Joanna Reynolds; Deborah DiLiberto; Lindsay Mangham-Jefferies; Evelyn K Ansah; Sham Lal; Hilda Mbakilwa; Katia Bruxvoort; Jayne Webster; Lasse S Vestergaard; Shunmay Yeung; Toby Leslie; Eleanor Hutchinson; Hugh Reyburn; David G Lalloo; David Schellenberg; Bonnie Cundill; Sarah G Staedke; Virginia Wiseman; Catherine Goodman; Clare I R Chandler
Journal:  Implement Sci       Date:  2014-06-17       Impact factor: 7.327

9.  Rivaroxaban for the treatment of venous thromboembolism in patients with nephrotic syndrome and low AT-III: A pilot study.

Authors:  Lihua Zhang; Haitao Zhang; Jiong Zhang; Hong Tian; Ju Liang; Zhihong Liu
Journal:  Exp Ther Med       Date:  2017-11-08       Impact factor: 2.447

10.  Safety and efficacy of Qishen granules in patients with chronic heart failure: study protocol for a randomized controlled trial.

Authors:  Jinping Wang; Jun Shi; Jiawei Wei; Juan Wang; Kuo Gao; Xueli Li; Jianxin Chen; Shaojing Li; Huihui Zhao; Wei Wang
Journal:  Trials       Date:  2017-10-10       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.